Nuvation Bio (NUVB)
(Delayed Data from NYSE)
$3.71 USD
+0.01 (0.27%)
Updated Oct 2, 2025 04:00 PM ET
After-Market: $3.73 +0.02 (0.54%) 5:26 PM ET
3-Hold of 5 3
F Value F Growth C Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, Nuvation Bio Inc. has a market cap of $1.27B, which represents its share price of $3.70 multiplied by its outstanding shares number of 342.27M. As a small-cap company, NUVB's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
NUVB 3.71 +0.01(0.27%)
Will NUVB be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for NUVB based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for NUVB
Nuvation Bio Inc. (NUVB) Just Flashed Golden Cross Signal: Do You Buy?
Nuvation Bio Inc. (NUVB) Reports Q2 Loss, Beats Revenue Estimates
NUVB: What are Zacks experts saying now?
Zacks Private Portfolio Services
Acadia Pharmaceuticals (ACAD) Tops Q2 Earnings and Revenue Estimates
All You Need to Know About Nuvation Bio (NUVB) Rating Upgrade to Buy
Nuvation Bio Inc. (NUVB) Reports Q1 Loss, Tops Revenue Estimates
Other News for NUVB
MACD Bullish Signal Line Cross appears for NUVB after 0.54% move
Is NUVB gaining bullish strength? Crossed Above 20 Day Moving Average shows up after soaring 14.91%
Nuvation Bio (NUVB) Surges 13% Following Phase 3 Enrollment and Buy Rating
NUVB Stock Surges: Key Developments Driving Growth
Nuvation Bio up after enrollment update, Jefferies’ bullish view